Your browser doesn't support javascript.
loading
Prognosis of pulmonary arterial hypertension patients with pericardial effusion before and after initiation of parenteral prostacyclin therapy.
Abu-Rmaileh, Muhammad; Mirza, Omer; Patel, Chandni; Shah, Trushil; Hardin, Elizabeth A; Bartolome, Sonja D; Chin, Kelly M.
Afiliação
  • Abu-Rmaileh M; UT Southwestern Department of Internal Medicine Dallas Texas USA.
  • Mirza O; UT Southwestern Department of Internal Medicine Dallas Texas USA.
  • Patel C; Division of Pulmonary and Critical Care Medicine UT Southwestern Medical Center Dallas Texas USA.
  • Shah T; UT Southwestern Department of Internal Medicine Dallas Texas USA.
  • Hardin EA; Division of Pulmonary and Critical Care Medicine UT Southwestern Medical Center Dallas Texas USA.
  • Bartolome SD; UT Southwestern Department of Internal Medicine Dallas Texas USA.
  • Chin KM; Division of Pulmonary and Critical Care Medicine UT Southwestern Medical Center Dallas Texas USA.
Pulm Circ ; 13(2): e12226, 2023 Apr.
Article em En | MEDLINE | ID: mdl-37063747
ABSTRACT
Few studies have evaluated the effects of pulmonary arterial hypertension therapies on pericardial effusion. We evaluated hemodynamics, echocardiograms, and outcomes for 119 parenteral prostanoid-treated patients. We discovered an increased frequency of pericardial effusions posttreatment, and that a moderate-large pericardial effusion at initiation, but not at 1st follow-up, was significantly associated with mortality.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pulm Circ Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pulm Circ Ano de publicação: 2023 Tipo de documento: Article